Evoke Pharma, Inc. and EVERSANA announced that Evoke, through its wide-scale commercialization partnership with EVERSANA, is launching a telehealth solution for patients. The new Direct-to-Patient Technology Solution will leverage EVERSANA's partnership with UpScriptHealth, a direct-to-consumer telehealth platform. The program allows patients who don't have regular access to care due to their remote location, lack of transportation, affordability, or work schedule to access care via a telehealth option.

UpScriptHealth's telehealth solution provides access to care from a licensed board-certified healthcare provider when it is convenient, generally a same-day appointment with a healthcare provider. This may allow for more rapid consultation and potentially treatment initiation within just a few days, if medically appropriate. People who have gastroparesis need options to support their ability to obtain relief of their symptoms that are often acute and debilitating.

In a recent survey of patients with gastroparesis: Over half reported their symptoms as being severe or very severe; 60% were not satisfied with available treatments for gastroparesis; When asked about their overall medical care, 1 out of 4 reported being dissatisfied.